GGrantIndex
Sort

25,944 grants matching neurodegeneration

The Role of Desoxysphingoid Bases in HSAN1

$431,224
Florian S Eichler · Massachusetts General Hospital · R01 · FY2011 · NS

Develop age-relevant glial cellular models using human directly reprogrammed cells

$431,200
Yanhong Shi · Beckman Research Institute/City Of Hope · R01 · FY2025 · AG

Pathways linking neuropsychiatric symptoms with Alzheimer's disease neuroimaging biomarkers and the outcome of incident Mild Cognitive Impairment/ Dementia

$431,163
Yonas E Geda · Mayo Clinic Arizona · R01 · FY2019 · AG

Pathways linking neuropsychiatric symptoms with Alzheimer's disease neuroimaging biomarkers and the outcome of incident Mild Cognitive Impairment/ Dementia

$431,163
Yonas E Geda · Mayo Clinic Arizona · R01 · FY2018 · AG

Molecular mechanisms of the mitochondrial permeability transition

$431,120
Evgeny Pavlov · New York University · R35 · FY2022 · GM

Molecular mechanisms of the mitochondrial permeability transition

$431,120
Evgeny Pavlov · New York University · R35 · FY2025 · GM

Molecular mechanisms of the mitochondrial permeability transition

$431,120
Evgeny Pavlov · New York University · R35 · FY2024 · GM

Molecular mechanisms of the mitochondrial permeability transition

$431,120
Evgeny Pavlov · New York University · R35 · FY2023 · GM

Dynamin-related protein 1 and mitochondrial fission adapters regulate presynaptic function

$430,998
Robert B Renden · University Of Nevada Reno · R01 · FY2024 · NS

CXCR3-Mediated Cell-Cell Communication in Glaucoma

$430,917
Wenbo Zhang · University Of Texas Med Br Galveston · R01 · FY2022 · EY

CXCR3-Mediated Cell-Cell Communication in Glaucoma

$430,917
Wenbo Zhang · University Of Texas Med Br Galveston · R01 · FY2025 · EY

CXCR3-Mediated Cell-Cell Communication in Glaucoma

$430,917
Wenbo Zhang · University Of Texas Med Br Galveston · R01 · FY2024 · EY

Regulated gene circuits for Alzheimer's disease therapy

$430,884
Jonathan Matthew Brunger · Vanderbilt University · R21 · FY2024 · AG

A Novel Neuroprotective Approach for Glaucoma

$430,755
Katalin T Prokai · University Of North Texas Hlth Sci Ctr · R01 · FY2016 · EY

DNA repair dysfunction in neurodegeneration

$430,745
Vilhelm A Bohr · National Institute On Aging · ZIA · FY2016 · AG

MITOCHONDRIA AND APOPTOSIS

$430,656
Burnham Institute For Medical Research · R01 · FY2003 · GM

Modeling Pathogenesis of Huntington's disease using patient-derived induced pluri

$430,500
Hongmin Wang · University Of South Dakota · R15 · FY2011 · NS

Biogenesis of macromolecular machines for post-transcriptional regulation of translation

$430,375
Homa Ghalei · Emory University · R35 · FY2025 · GM

Circadian disruption as an accelerator of synucleinopathy

$430,375
Timothy J. Collier · Michigan State University · R21 · FY2022 · NS

Novel Wnt activators for Alzheimer's disease therapy

$430,375
Yonghe Li · Mayo Clinic Jacksonville · R21 · FY2020 · AG

Protective actions of the anti-inflammatory drug candidate 10-nitro-oleic acid in Parkinson’s disease

$430,375
Marco Fazzari · University Of Pittsburgh At Pittsburgh · R21 · FY2019 · NS

Glycogen promotes protein aggregation in ALS and FTD

$430,375
Yongjie Zhang · Mayo Clinic Jacksonville · R21 · FY2022 · NS

The role of Selenoprotein I in mitigating neurodegeneration.

$430,375
Matthew William Pitts · University Of Hawaii At Manoa · R21 · FY2023 · NS

Gut microbial metabolite-mediated neuroprotection in traumatic brain injury

$430,375
Dennis William Simon · University Of Pittsburgh At Pittsburgh · R21 · FY2020 · NS

Abnormal Hyperphosphorylation of Tau

$430,357
Khalid Iqbal · Institute For Basic Res In Dev Disabil · R01 · FY2009 · AG